196 related articles for article (PubMed ID: 34715068)
21. Management of hepatic encephalopathy in patients with cirrhosis.
Wright G; Jalan R
Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections.
Merli M; Lucidi C; Pentassuglio I; Giannelli V; Giusto M; Di Gregorio V; Pasquale C; Nardelli S; Lattanzi B; Venditti M; Riggio O
J Hepatol; 2013 Aug; 59(2):243-50. PubMed ID: 23523580
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia.
Mardini H; Smith FE; Record CO; Blamire AM
J Hepatol; 2011 Jun; 54(6):1154-60. PubMed ID: 21145802
[TBL] [Abstract][Full Text] [Related]
24. Effect of sirolimus on liver cirrhosis and hepatic encephalopathy of common bile duct-ligated rats.
Wu KC; Huang HC; Chang T; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Lee FY; Chang CC; Lee SD
Eur J Pharmacol; 2018 Apr; 824():133-139. PubMed ID: 29444470
[TBL] [Abstract][Full Text] [Related]
25. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment.
Van Thiel DH; Fagiuoli S; Wright HI; Chien MC; Gavaler JS
Hepatology; 1994 Jan; 19(1):67-71. PubMed ID: 8276369
[TBL] [Abstract][Full Text] [Related]
26. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications.
Erceg S; Monfort P; Cauli O; Montoliu C; Llansola M; Piedrafita B; Felipo V
Neurochem Int; 2006; 48(6-7):441-6. PubMed ID: 16497413
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the event-related potential (ERP-P300) in patients with hepatic cirrhosis without encephalopathy].
Teodoro V; Bragagnolo M; Lucchesi L; Kondo M; Tufik S
Arq Gastroenterol; 2008; 45(1):82-6. PubMed ID: 18425234
[TBL] [Abstract][Full Text] [Related]
28. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy.
Rodrigo R; Cauli O; Gomez-Pinedo U; Agusti A; Hernandez-Rabaza V; Garcia-Verdugo JM; Felipo V
Gastroenterology; 2010 Aug; 139(2):675-84. PubMed ID: 20303348
[TBL] [Abstract][Full Text] [Related]
29. Modern progress in hepatic encephalopathy.
McPhail MJ; Senvar N; Thomas HC; Taylor-Robinson SD
QJM; 2010 Nov; 103(11):899-900. PubMed ID: 20356851
[No Abstract] [Full Text] [Related]
30. Characteristics of minimal hepatic encephalopathy.
Amodio P; Montagnese S; Gatta A; Morgan MY
Metab Brain Dis; 2004 Dec; 19(3-4):253-67. PubMed ID: 15554421
[TBL] [Abstract][Full Text] [Related]
31. Magnesium Deficiency and Minimal Hepatic Encephalopathy among Patients with Compensated Liver Cirrhosis.
Cohen-Hagai K; Feldman D; Turani-Feldman T; Hadary R; Lotan S; Kitay-Cohen Y
Isr Med Assoc J; 2018 Sep; 20(9):533-538. PubMed ID: 30221864
[TBL] [Abstract][Full Text] [Related]
32. Hepatic encephalopathy as a complication of liver cirrhosis: an Asian perspective.
Moriwaki H; Shiraki M; Iwasa J; Terakura Y
J Gastroenterol Hepatol; 2010 May; 25(5):858-63. PubMed ID: 20546438
[TBL] [Abstract][Full Text] [Related]
33. Modulation of GABAA receptors by neurosteroids. A new concept to improve cognitive and motor alterations in hepatic encephalopathy.
Agusti A; Llansola M; Hernández-Rabaza V; Cabrera-Pastor A; Montoliu C; Felipo V
J Steroid Biochem Mol Biol; 2016 Jun; 160():88-93. PubMed ID: 26307490
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.
Yadav SK; Goel A; Saraswat VA; Thomas MA; Wang E; Marincola FM; Haris M; Gupta RK
J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420
[TBL] [Abstract][Full Text] [Related]
35. Clinical management of hepatic encephalopathy.
Schiano TD
Pharmacotherapy; 2010 May; 30(5 Pt 2):10S-5S. PubMed ID: 20412035
[TBL] [Abstract][Full Text] [Related]
36. Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy.
Guevara M; Baccaro ME; Gómez-Ansón B; Frisoni G; Testa C; Torre A; Molinuevo JL; Rami L; Pereira G; Sotil EU; Córdoba J; Arroyo V; Ginès P
J Hepatol; 2011 Sep; 55(3):564-573. PubMed ID: 21163310
[TBL] [Abstract][Full Text] [Related]
37. Disruption of sleep architecture in minimal hepatic encephalopathy and ghrelin secretion.
Bajaj JS; Saeian K; Schubert CM; Franco R; Franco J; Heuman DM
Aliment Pharmacol Ther; 2011 Jul; 34(1):103-5. PubMed ID: 21631553
[No Abstract] [Full Text] [Related]
38. Hepatic Encephalopathy Aggravated by Systemic Inflammation.
Manzhalii E; Virchenko O; Falalyeyeva T; Moiseienko V; Nykula T; Kondratiuk V; Savchuk O; Beregova T; Stremmel W
Dig Dis; 2019; 37(6):509-517. PubMed ID: 31170723
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori and hepatic encephalopathy.
Duseja A; Sachdev A; Dhiman RK; Chawla YK
Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S31-2. PubMed ID: 15025251
[TBL] [Abstract][Full Text] [Related]
40. Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients.
Barboza KC; Salinas LM; Sahebjam F; Jesudian AB; Weisberg IL; Sigal SH
Metab Brain Dis; 2016 Aug; 31(4):869-80. PubMed ID: 27032930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
